Methyldopa has been used in the treatment of high blood pressure for more than 50 years. WHO has also included Methylpodia in the list of essential medicines. According to the Journal of Clinical Investigation, due to the compound called 'DQ8', the victim is diabetic. Diabetes can also be prevented by controlling this compound.
Researchers used drugs approved by the Food and Drug Administration for the study. With the help of supercomputer, the complex structure of HLA i.e. was linked to DQ-8. Then the effect of thousands of medicines on them was analyzed alternately. Research found that Mithydodopa blocked the DQ8 without harming the body's immune system. After using 10 years of mice on rats, it was also clinical trial on 20 patients suffering from diabetes.